| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 28,111 | |||
| Accounts receivable - trade | 65 | |||
| Investments in debt securities (adjusted cost 21,471 and 0, respectively - see note 6) | 21,456 | |||
| Prepaid expenses and other current assets | 1,140 | |||
| Total current assets | 50,772 | |||
| Restricted cash | 228 | |||
| Promissory note receivable | 1,118 | |||
| Operating lease right-of-use asset | 1,958 | |||
| Fixed assets, net of accumulated depreciation | 3,210 | |||
| Intangible assets, net of accumulated amortization | 6,843 | |||
| Security deposits | 26 | |||
| Total assets | 64,155 | |||
| Accounts payable | 2,822 | |||
| Accrued expenses | 850 | |||
| Operating lease obligation - current portion | 504 | |||
| Equipment financing payable - current portion | 16 | |||
| Term promissory note | 706 | |||
| Contract liabilities | 1,150 | |||
| Total current liabilities | 6,048 | |||
| Operating lease obligation - net of current portion | 2,068 | |||
| Total liabilities | 8,116 | |||
| Common stock - 0.001 par value 275,000,000 shares authorized at september 30, 2025 and june 30, 2025 20,254,599 and 19,349,201 shares issued and outstanding as of september 30, 2025 and june 30, 2025, respectively | 20 | |||
| Additional paid-in capital | 393,978 | |||
| Accumulated other comprehensive loss | -15 | |||
| Accumulated deficit | -337,944 | |||
| Total stockholders' equity | 56,039 | |||
| Total liabilities and stockholders' equity | 64,155 | |||
iBio, Inc. (IBIO)
iBio, Inc. (IBIO)